Skip to main content

Advertisement

SpringerLink
Log in

Ixazomib-induced Sweet’s syndrome

  • Images in Hematology
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Author information

Authors and Affiliations

  1. Hematology and Oncology Division, Hitachi General Hospital, 2-1-1 Jonancho, Hitachi, Ibaraki, 317-0077, Japan

    Takuya Suyama & Atsushi Shinagawa

  2. Dermatology Division, Hitachi General Hospital, Hitachi, Ibaraki, Japan

    Syusaku Ito

Authors
  1. Takuya Suyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Syusaku Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Atsushi Shinagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takuya Suyama.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Informed consent

Informed consent was received from the patients for publication.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Suyama, T., Ito, S. & Shinagawa, A. Ixazomib-induced Sweet’s syndrome. Int J Hematol 111, 161–162 (2020). https://doi.org/10.1007/s12185-019-02797-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-019-02797-6

Keywords

Search

Navigation